Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
5.12
+0.17 (3.43%)
At close: May 27, 2026, 4:00 PM EDT
5.22
+0.10 (1.95%)
After-hours: May 27, 2026, 7:39 PM EDT
Atossa Therapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Atossa Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $22.75. The average 1-year stock price forecast is 344.34% higher than the current stock price, while the lowest is $20 (+290.62%) and the highest is $25 (+388.28%).
Price Target: $22.75 (+344.34%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Atossa Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $19 → $20 | Buy | Reiterates | $19 → $20 | +290.62% | May 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $25 | Buy | Maintains | $25 | +388.28% | May 8, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $24 | Buy | Maintains | $24 | +368.75% | Apr 9, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $35 → $10 | Buy | Maintains | $35 → $10 | +95.31% | Feb 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.50
from -4.04
EPS Next Year
-2.21
from -4.50
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -4.40 | -0.51 | |||
| Avg | -4.50 | -2.21 | |||
| Low | -4.55 | -3.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.